Carter Martha J. 4
4 · ALBIREO PHARMA, INC. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Carter Martha J.
Chief Regulatory Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-18+15,900→ 15,900 totalExercise: $26.75Exp: 2032-01-17→ Common Stock (15,900 underlying) - Award
Common Stock
2022-01-18+10,800→ 16,300 total
Footnotes (3)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.
- [F2]Represents 16,300 restricted stock units.
- [F3]This option vests as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.